Founder, Managing Director
CurrentNew Drug & Medical Device Development:Clinical Research: Phase I, II, III, IV1. For Biotech /Pharma /Device Companies:- Clinical development (translational research, phase I, II, III, & IV clinical trials) * Clinical program & strategies * KOL engagement * FDA interactions & negotiation * Clinical trial planning, launch, execution, monitoring, & close out * Clinical trial exposure (clinicaltrials.gov) * Medical affairs * Safety and pharmacovigilance- Special Services: Crisis management for clinical program, medical affairs, and safety- Product evaluation, due diligence assessment for in-licensing, M&A needs- Company pipeline, product development progress evaluation2. For Investors, Investment Firms- Evaluation of clinical program, status, and progress- Product evaluation, due diligence assessment for in-licensing, M&A needs- Company pipeline, product development progress evaluation
